© The Author(s) Published by Science and Education Publishing.

Slides:

Advertisements

Similar presentations

Cinnamon: Not Your Grandma’s Spice Anymore Christie Seibert, MD Primary Care Conference May 14, 2008.

Advertisements

Effect of 21-day Holistic Therapy at “Our Native Village Eco Resorts” on Diabetes Mellitus as assessed by blood glucose levels and consumption of oral.

KINDS OF BLOOD TESTS. A-1-C HEMOGLOBIN ABO BLOOD TYPE.

Philip J. Barter, et al. Circulation 2011;124:

© 2003, Wellsource Inc. Effect of Ketogenic Diet on Lipid Levels (shown is LDL-C) In this group of 141 children followed for 6 months, a ketogenic diet.

Section IV. Routine and Optional Laboratory Tests for the Investigation of Patients with Hypertension 2015 Canadian Hypertension Education Program Recommendations.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.

Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:

Table 1. Clinical characteristics of subjects Mean ± s.d. n1363 Age (years)55.6 ± 14.1 Genders, % Males49.1 Females50.9 Diabetes, %44.9 Hypertension, %14.0.

Liver cholesterol (mg/g)

Parameters BD PP CP TC (mg. dl-l) ± * ± 5.8

© The Author(s) Published by Science and Education Publishing.

© The Author(s) Published by Science and Education Publishing.

Figure 2. Effect of Siberian and Panax ginseng respectively on postprandial glucose level before and after three months of intake in patients with type.

© The Author(s) Published by Science and Education Publishing.

Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.

Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride.

Steamed black soybeans

© The Author(s) Published by Science and Education Publishing.

Nonproliferative DR (n=24)

Copyright © 2002 American Medical Association. All rights reserved.

WHAT IS THE REAL NORMAL RANGE?

© The Author(s) Published by Science and Education Publishing.

Table 6. Frequency of RTEC Consumption in Terms of Gender

Paleolithic ketogenic diet

Table 1. Formulation of gluten-free cake

© The Author(s) Published by Science and Education Publishing.

Table 1. Composition of the diet (g/kg)

Basic laboratory testing

Time frame : Baseline to post intervention

AGA KHAN UNIVERSITY HOSPITAL EID-UL-ADHA MUBARAK.

End point Muraglitazar 5 mg plus metformin (n=569)

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Kendra K. Kattelmann, PhD, RD: South Dakota State University (SDSU)

Sodium-glucose co-transporter 2 (SGLT2) inhibitors work by blocking the reabsorption of filtered glucose in the kidneys. This leads to glucosuria and improved.

Effect of evolocumab on lipoprotein particles

Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial Erik S.G. Stroes, MD, PhD, Andrey.

Flowchart of literature search for the effect of fructose on glycemic end points (fasting glucose, fasting insulin, and glycated blood proteins [HbA1c.

Hajer GR et al. Atherosclerosis 2009;202:216-24

Patient flow chart: the final prospective study population consisted of 521 individuals, 113 on basal insulin and 408 on OADs. *Plausibility: height (130–230 cm),

Screening, enrollment, and randomization of study participants (BMI, body mass index; CTG, conventional therapy group; HbA1c, glycated hemoglobin; HDL-C,

© The Author(s) Published by Science and Education Publishing.

Table 5. Sensory evaluation of mayonnaise samples

Kendra K. Kattelmann, PhD, RD: South Dakota State University (SDSU)

Body mass, BMI, plasma lipids, lipoproteins, and glucose homeostasis at baseline, and following placebo and rosuvastatin periods Dmitri Sviridov et al.

Receiver operating characteristic analyses showing area under the curves with reference to 2-hour OGTT (A,B) and fasting plasma glucose (C,D). HbA1c, glycated.

Flow of Patients Through Trial

Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials Allan D. Sniderman, MD, James A. Sloand,

(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.

PROSPER: trial design

© The Author(s) Published by Science and Education Publishing.

Monitoring for diabetic complications in home care baseline data

Change in markers of glycometabolism and cardiovascular risk profile.

diabetic rats treated with BPHs

Improved monitoring of diabetic parameters outcome data

Supplementary table 1 Supplementary table 1. Serum biochemistry data and hepatic lipid profiles after drinking water or 20% ethanol for 4 weeks Parameters.

Individual lipid measures for high-carbohydrate (n=10) and low-carbohydrate (n=10) ultra-endurance athletes. Individual lipid measures for high-carbohydrate.

© The Author(s) Published by Science and Education Publishing.

Table 3. Sugar contents of the examined food samples (g/100 g)

Research, 2016, Vol. 4, No. 6, doi: /jfnr-4-6-2

Table 1. Controlled clinical trial selected to review

Table 2. Experimental research selected to review

© The Author(s) Published by Science and Education Publishing.

Solid-liquid ratio (B)

Risk of mortality in patients with diabetes and ESRD

© The Author(s) Published by Science and Education Publishing.

Research, 2016, Vol. 4, No. 6, doi: /jfnr-4-6-2

Time course of daily basal and mealtime insulin dose (A), glycated hemoglobin (B), laboratory-measured clinic FPG (C), prebreakfast SMPG (D), SMPG profiles.

Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.

Ingredients/100g dry sample

Presentation transcript:

© The Author(s) 2015. Published by Science and Education Publishing. Table 3. Intervention wise diabetic, lipid, hepatic & urinary profile in three phases of the study Parameters Baseline After 3 months intervention Washout period Overall effect within group Overall effect between group Placebo chromium P. value within group Chromium Picolinate Diabetic Profile FPG (mg/dl) 149.58 ±22.90 142.85 ±17.71 0.209 143.26 ±36.07 130.42 ±32.68 0.38 128.38 ±26.39 129.14 ±22.40 0.281 0.003 0.000 Insulin (µIU/mL) 24.47 ±16.49 33.37 ±28.3 0.394 22.66 ±12.01 24.72 ±23.2 0.472 20.18 ±11.88 24.33 ±22.7 0.474 0.037 HbA1C (%) 7.78 ±0.92 7.98 ±1.28 0.432 6.50 ±0.76 6.12 ±0.89 0.337 6.02 ±0.82 6.04 ±0.81 0.538 Lipid Profile Cholesterol 179.4 ±31.4 189.2 ±40.1 0.387 177 ±34.8 167±34 0.473 168 ±21.6 165.2 ±32.2 0.429 0.102 0.612 Triglyceride 180.4 ±83.1 193.2 ±158.4 0.418 192.2 ±71.3 148.4 ±46.3 0.323 163.54 ±34.14 163.50 ±45.7 0.131 0.923 HDL 38.2 ±9.2 38.6 ±12.8 0.445 43.4 ±11.07 42 ±11.4 0.446 46.4 ±10 44.6 ±11.5 0.613 0.645 0.565 LDL 109.5 ±30.2 111.7 ±42.4 0.335 104 ±29.8 98.1 ±38.6 0.489 103.8 ±24.03 97.09 ±46.1 0.363 0.119 0.861 VLDL 36.08 ±16.62 38.63 ±31.67 32.70 ±6.82 ±9.14 0.414 0.504 Hepatic Profile ALT (IU/L) 43.42 ±28.12 52.88 ±42.7 0.485 39.16 ±27.32 42.67 ±27.3 0.440 32 ±19.58 40.36 ±24.1 0.283 0.007 ALP 105.85 108.77 ±34.2 0.546 105.43 ±31.42 92.64 109 ±33.13 84 ±19.5 0.428 0.025 Urinary Profile UMA (mg) 24.34 ±24.84 25.17 ±27.7 26.82 ±43.48 26.11 ±27.5 28.83 ±43.46 24.94 ±26.8 0.420 0.393 0.999 Urinary Protein 32.84 ±30.30 106.5 ±336 0.434 20.28 ±17.57 50.46 ±62.4 0.395 27.3 ±16.8 19.34 ±10.4 0.301 0.450 Urinary creatinine (mg/dL) 112.4 ±61.01 126.8 ±86.3 0.433 93.63 ±55.73 83.91 ±60.3 0.476 108 ±48.8 119.2 ±54.2 0.392 0.215 0.099 FPG= Fasting Plasma Glucose, HbA1C= Glycated Hemoglobin, HDL = High Density Lipoprotein, LDL = Low Density Lipoprotein, VLDL = Very Low Density Lipoprotein, UMA =Urinary Micro Albumin Hajra Ahmad et al. Effect of Chromium Picolinate Supplementation on Diabetic Profile and Nutritional Status of the Type-2 Diabetic Adult Population – A Randomized Controlled Trial. Journal of Food and Nutrition Research, 2016, Vol. 4, No. 8, 535-542. doi:10.12691/jfnr-4-8-8 © The Author(s) 2015. Published by Science and Education Publishing.